Edesa Biotech, Inc. (EDSA)
Nasdaq: EDSA · Pharmaceutical Preparations · filing with the SEC since 2012
Who owns Edesa Biotech, Inc.
As filed with the SECHolders of 5% or more
7
Pardeep Nijhawan holds 16.3% of Common Shares, no par value per share, as its SCHEDULE 13D/A filed Aug 25, 2026 says.
Directors and officers
9
report now, of 25 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Pardeep Nijhawan
SCHEDULE 13D/A · filed Aug 25, 2026 · Common Shares, no par value per share · 20% in Jun 16, 2026
Velan Capital Investment Management LP
SCHEDULE 13D/A · filed Aug 25, 2026 · Common Shares, without par value · 9.99% in Mar 2, 2026
Rubric Capital Management LP
SCHEDULE 13G · filed May 15, 2026 · Common Shares, no par value
Sirenia Capital Management LP
SCHEDULE 13G · filed May 15, 2026 · Common Shares, without par value
Stonepine Capital Management, LLC
SCHEDULE 13G · filed Aug 26, 2026 · Common Shares · 0.3% in May 15, 2026
Perceptive Advisors LLC
SCHEDULE 13G · filed Mar 16, 2026 · Common Shares, without par value
Integrated Core Strategies (US) LLC
SCHEDULE 13G · filed Jun 18, 2026 · Common Shares, without par value
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Shares, without par value · reported falling below 5%, from 9.99% in Feb 13, 2026
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Shares, without par value · reported falling below 5%, from 7.2% in Mar 3, 2026
Thomas A. Satterfield, Jr.
SCHEDULE 13G/A · filed Feb 18, 2025 · Common Stock, without par value · reported falling below 5%, from 6.7% in Feb 12, 2025
What EDSA reports owning in othersstakes of 5% or more, and other ties
Edesa Biotech, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
9purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 25 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Nijhawan Pardeep | Chief Executive Officer | 0 | $0 | 0 | 8 | $200,000 |
| Brooks Michael J | President | 0 | $0 | 0 | 1 | $0 |